Cargando…
Immune modulation of i.v. immunoglobulin in women with reproductive failure
BACKGROUND: The mechanism of maternal immune tolerance of the semi‐allogenic fetus has been explored extensively. The immune reaction to defend from invasion by pathogenic microorganisms should be maintained during pregnancy. An imbalance between the immune tolerance to the fetus and immune activati...
Autores principales: | Han, Ae R., Lee, Sung K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902469/ https://www.ncbi.nlm.nih.gov/pubmed/29692668 http://dx.doi.org/10.1002/rmb2.12078 |
Ejemplares similares
-
Intravenous immunoglobulin G in women with reproductive failure: The Korean Society for Reproductive Immunology practice guidelines
por: Sung, Nayoung, et al.
Publicado: (2017) -
Effectiveness of high‐dose i.v. immunoglobulin therapy for pregnant women with aspirin–heparin‐resistant secondary antiphospholipid syndrome
por: Maesawa, Yoko, et al.
Publicado: (2018) -
Iron i.v. in heart failure: ready for implementation?
por: Rocca, Hans-Peter Brunner-La, et al.
Publicado: (2015) -
COVID-19 and immunomodulation treatment for women with reproductive failures
por: Kwak-Kim, Joanne, et al.
Publicado: (2020) -
The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia
por: Uzun, Günalp, et al.
Publicado: (2021)